Abiopharma

Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright

24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets

Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright

24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets

Catalyst Pharmaceuticals Announces Settlement ofFIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Ardelyx to Participate in Upcoming Investor Conferences

Fate Therapeutics to Present at Upcoming Investor Conferences

HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market

4DMT to Participate in Upcoming Investor Conferences

NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in September

Spectral Medical Receives US$3 Million From Vantive

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

Immuneering Announces Clinical Supply Agreement with Lilly to Evaluate Atebimetinib in Combination with Olomorasib

New Form 8-K - IMMUCELL CORP /DE/ Filed: 2025-08-25 AccNo: 0001213900-25-080110 Size: 205 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits